Rab Diagnostics presentation at LSX Nordic Congress in Bergen 2025

Rab Diagnostics at LSX Nordic Congress 2025 | Advancing Biomarker Innovation for ADCs

Rewatch Rab Diagnostics’ presentation from the LSX Nordic Congress 2025 in Bergen. In this session, we share how our team is pioneering the next generation of oncology-focused biomarker development to support Antibody-Drug Conjugate (ADC) innovation.

Through our proprietary RabCANCER platform and leading expertise in intracellular drug trafficking, we enable biopharma partners to make smarter, mechanism-driven decisions in drug development. By translating cutting-edge research into robust diagnostic tools and biomarker kits, we help bridge the translational gap, enabling precision medicine.

Headquartered in Oslo, Norway, and built on research from Oslo University Hospital, Rab Diagnostics is committed to scientific excellence and strategic collaboration. Watch this presentation to learn how we’re driving progress in ADC biomarker science and accelerating the delivery of effective, targeted cancer therapies.

Click the video to watch the presentation of Rab Diagnostics at the LSX Nordic Congress in Bergen, May 2025